Skip to main content

Doctoral thesis in Immunotechnology: Combating cancer in the bladder

A new type of cancer treatment is emerging that uses the body's own immune system to fight cancer. This works clinically and is currently used in various ways to treat different types of cancer.

Tord Hjalt – Published 1 October 2025

Laboratory environment. Photo.
Viktor Sincic, doctoral student in Immunotechnology, is now defending his thesis on the treatment of bladder cancer. Photo: Kennet Ruona

Viktor Sincic, a doctoral student in Immunotechnology, has studied cancer in the bladder. Existing immunotherapy methods can be effective in fighting cancer, but not for all patients. Viktor Sincic has mapped the local immune system in bladders and found a cell surface receptor which, when blocked by an antibody, boosts the immune system and kills the cancer more effectively.

In the future, this knowledge can be used to strengthen the immune response to bladder cancer in more patients than before.

Viktor Sincic will defend his thesis on October 10:
Decoding immune heterogeneity in bladder cancer: From cellular cartography to ex vivo models and antibody-based targeting

Read more about Viktor Sincic's research in Lund University's research portal:
https://portal.research.lu.se/en/persons/viktor-sincic